Healthcare

Medicare Drug Price Negotiation: Manufacturer Participation in Third Cycle

CMS announced that 15 drug manufacturers have chosen to participate in the third cycle of Medicare drug price negotiations. These negotiations, part of the Inflation Reduction Act, will determine prices for selected high-expenditure drugs, with negotiated prices effective beginning in 2028.

NY Health Urges Colorectal Cancer Screening for Adults Under 50

The New York State Department of Health is urging adults aged 45 and older to undergo colorectal cancer screening, as it is now a leading cause of cancer death for those under 50. The department highlights that screening can prevent or detect the cancer early, and aims to improve current screening rates.

Colorado Identifies Additional Measles Cases

Colorado public health officials announced two additional measles cases in Broomfield County, with a third under investigation. The notice identifies a potential public exposure location and advises individuals to seek vaccination or medical consultation if exposed.

Colorado MMR Vaccine Reminder Program

The Colorado Department of Public Health and Environment is sending reminders to approximately 200,000 children who may be overdue for their MMR vaccine. This outreach is part of a routine public health program and occurs during a national surge in measles cases.

AHRQ Stats: Healthcare Quality Statistics on Adverse Events, Maternal Deaths, Opioid Use

The Agency for Healthcare Research and Quality (AHRQ) has released updated statistics on healthcare quality. The data highlights adverse drug events involving hypoglycemic agents, disparities in healthcare expenditures by race/ethnicity, and maternal death rates by income and race/ethnicity.

AHRQ Press Releases on Patient Safety, Quality, and Research

The Agency for Healthcare Research and Quality (AHRQ) publishes press releases regarding patient safety, quality, and research. Recent releases cover topics such as a new dashboard for tracking patient harm reduction, reports on sepsis burden, and funding opportunities for state-based health improvement solutions.

AHRQ Social Media Presence Update

The Agency for Healthcare Research and Quality (AHRQ) has updated its social media presence, providing links to its official accounts on platforms including Instagram, Facebook, LinkedIn, and YouTube. This notice informs the public about where to find AHRQ research, tools, and training information online.

AHRQ Impact Case Studies Highlight Evidence-Based Tools

The Agency for Healthcare Research and Quality (AHRQ) has published new impact case studies highlighting the use of its evidence-based tools and publications. These studies showcase how various healthcare organizations and policymakers have successfully implemented AHRQ resources to improve healthcare quality and safety.

HRSA Lowers Out-of-Pocket Medication Costs at Health Centers

The Health Resources and Services Administration (HRSA) has issued updated award terms requiring HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program. This action aims to lower out-of-pocket costs for life-saving medications nationwide.

HRSA Health Centers Served Record 32.4 Million Patients in 2024

The Health Resources and Services Administration (HRSA) announced that HRSA-funded health centers served a record 32.4 million patients in 2024. The data highlights quality improvements and recognizes nearly 1,000 health centers with Community Health Quality Recognition badges.